Showing results (131-140 of 323) with videos related to
Sort By:
Pageof 33
Biochemistry|April 16, 1996
Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cellsK M Barnes, B Dickstein, G B Cutler, et al.Biochemistry|September 7, 1993
Differential modulation of P-glycoprotein transport by protein kinase inhibitionS E Bates, J S Lee, B Dickstein, et al.Gynecologic Oncology|August 6, 2000
Phase II study of liposomal doxorubicin in advanced gynecologic cancersV P Israel, A A Garcia, L Roman, et al.Journal of Neuro-Oncology|August 10, 2000
Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiformeM A Rosenthal, M L Gruber, J Glass, et al.Cancer Treatment Reports|March 1, 1984
Phase II trial of PALA in lymphoma: an Eastern Cooperative Oncology Group studyF M Muggia, A A Tsiatis, M J O'Connell, et al.Human Gene Therapy|January 1, 1991
Implantation of recombinant rat myocytes into adult skeletal muscle: a potential gene therapyA Salminen, H F Elson, L A Mickley, et al.The Journal of Clinical Investigation|April 15, 1997
Gene rearrangement: a novel mechanism for MDR-1 gene activationL A Mickley, B A Spengler, T A Knutsen, et al.Biochemical Pharmacology|December 24, 1996
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panelO Rixe, W Ortuzar, M Alvarez, et al.Journal of the National Cancer Institute|April 20, 2000
Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategyD Vandier, V Calvez, L Massade, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance geneA T Fojo, D W Shen, L A Mickley, et al.Pageof 33